The drug content in adhesive mixtures for inhalation is known to influence their dispersion performance, but the direction and magnitude of this influence depends on other variables. In the past decades several mechanisms have been postulated to explain this finding and a number of possible interacting variables have been identified. Still, the role of drug content in the formulation of adhesive mixtures for inhalation, which includes its significance as an interacting variable to other parameters, is poorly understood. Therefore, the results from a series of drug detachment experiments are presented in which the effect of drug content and its dependence on flow rate, the mixing time and the type of drug is studied. Furthermore, it is investigated whether the effect depends on the range within which the drug content is changed. Quantitative and qualitative multiple order interactions are observed between these variables, which may be explained by a shifting balance between three different mechanisms. The results therefore demonstrate that accounting for (multiple order) interactions between variables has to be part of quality by design activities and the rational design of future experiments.
References
[1]
Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M (1994) Drug delivery to the respiratory tract using dry powder inhalers. International Journal of Pharmaceutics 101: 1–13.
[2]
Staniforth JN (1981) Total Mixing. Int J Pharm Tech & Prod Mfr 2: 7–12.
[3]
Staniforth JN (1987) British Pharmaceutical Conference Science Award Lecture 1986: Order out of chaos. Journal of Pharmacy and Pharmacology 39: 329–334.
[4]
Hersey JA (1975) Ordered mixing: A new concept in powder mixing practice. Powder Technology 11: 41–44.
[5]
Bryan L, Rungvejhavuttivittaya Y, Stewart PJ (1979) Mixing and demixing of microdose quantities of sodium-salicylate in a direct compression vehicle. Powder Technology 22: 147–151.
[6]
Kulvanich P, Stewart PJ (1987) The effect of particle size and concentration on the adhesive characteristics of a model drug-carrier interactive system. Journal of Pharmacy and Pharmacology 39: 673–678.
[7]
Steckel H, Markefka P, teWierik H, Kammelar R (2004) Functionality testing of inhalation grade lactose. European Journal of Pharmaceutics and Biopharmaceutics 57: 495–505.
[8]
Steckel H, Muller BW (1997) In vitro evaluation of dry powder inhalers.2. Influence of carrier particle size and concentration on in vitro deposition. International Journal of Pharmaceutics 154: 31–37.
[9]
Le VNP, Hoang Thi TH, Robins E, Flament MP (2012) In vitro evaluation of powders for inhalation: The effect of drug concentration on particle detachment. International Journal of Pharmaceutics 424: 44–49.
[10]
Young PM, Edge S, Traini D, Jones MD, Price R, et al. (2005) The influence of dose on the performance of dry powder inhalation systems. International Journal of Pharmaceutics 296: 26–33.
[11]
de Boer AH, Dickhoff BHJ, Hagedoorn P, Gjaltema D, Goede J, et al. (2005) A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation. International Journal of Pharmaceutics 294: 173–184.
[12]
Louey MD, Stewart PJ (2002) Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures. Pharmaceutical Research 19: 1524–1531.
[13]
de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, et al. (2004) The Mode of Drug Particle Detachment from Carrier Crystals in an Air Classifier-Based Inhaler. Pharmaceutical Research 21: 2167–2174.
[14]
de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, et al. (2004) The Rate of Drug Particle Detachment from Carrier Crystals in an Air Classifier-Based Inhaler. Pharmaceutical Research 21: 2158–2166.
[15]
Dickhoff BHJ, de Boer AH, Lambregts D, Frijlink HW (2003) The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time. European Journal of Pharmaceutics and Biopharmaceutics 56: 291–302.
[16]
Lam KK, Newton JM (1991) Investigation of applied compression on the adhesion of powders to a substrate surface. Powder Technology 65: 167–175.
[17]
de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW (2003) Air classifier technology (ACT) in dry powder inhalation: Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. International Journal of Pharmaceutics 260: 187–200.
[18]
De Koning JP (2001) Dry powder inhalation. The Netherlands: University of Groningen.
[19]
Dickhoff BHJ (2006) Adhesive mixtures for powder inhalation. The Netherlands: University of Groningen.
[20]
de Boer AH, Chan HK, Price R (2012) A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Advanced Drug Delivery Reviews 64: 257–274.
[21]
Jones M, Hooton J, Dawson M, Ferrie A, Price R (2008) An Investigation into the Dispersion Mechanisms of Ternary Dry Powder Inhaler Formulations by the Quantification of Interparticulate Forces. Pharmaceutical Research 25: 337–348.
[22]
Hooton JC, Jones MD, Price R (2006) Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive–adhesive force balance approach. Journal of Pharmaceutical Sciences 95: 1288–1297.
[23]
Price R (2010) Low and High Energy Blending. Presentation at conference: Lactose as a carrier for inhalation products. Parma.
[24]
Jones MD, Harris H, Hooton JC, Shur J, King GS, et al. (2008) An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. European Journal of Pharmaceutics and Biopharmaceutics 69: 496–507.
